Evidence library


TBS publications

More than 1,600 peer-reviewed publications underpin Trabecular Bone Score® (TBS®) as the global standard in bone microarchitecture assessment.

Filter a curated database of publications below, or search PubMed for all TBS® publications.

Filter by keyword:

2025

Spine

Diagnosing Osteoporosis for the Spine Practitioner

Anderson, P.A. and Binkley, N.C.

Diagnosis

2025

Frontiers in Medicine

Assessment of Bone Health in Pre-Dialysis CKD Patients Based on TBS Reference Range for the Chinese Population

Wu, B., Wu, H., Wang, Z., Tan, Z., Guo, B., Shang, J., Cheng, Y., Zeng, C., Jiang, Y., Cai, Q., Gong, J. and Xu, H.

Fracture Risk AssessmentSecondary Osteoporosis

2025

Archives of Osteoporosis

Reference Curves for Trabecular Bone Score Adjusted for Soft Tissue Thickness in Children and Adolescents from Mexico City

Guagnelli, M.A., Lopez-Gonzalez, D., Hind, K., Shevroja, E., Hans D., Clark P.

Pediatrics

2025

Osteologie

Trabecular Bone Score: From Over a Decade of Evidence to a Connected Bone Health Ecosystem

Hind, K., Davies, M., Gonzalez-Rodriguez, E. and Hans, D.

Fracture Risk AssessmentPrimary OsteoporosisSecondary Osteoporosis

2024

The Journal of Clinical Endocrinology and Metabolism

Trabecular Bone Score as a Marker of Skeletal Fragility Across the Spectrum of Chronic Kidney Disease: A Systematic Review and Meta-analysis

Bioletto, F., Barale, M., Maiorino, F., Pusterla, A., Fraire, F., Arvat, E., Ghigo, E., Procopio, M.

EndocrinologyFracture Risk AssessmentNephrologySecondary Osteoporosis

2024

Journal of Endocrinological Investigation

Denosumab Improves Trabecular Bone Score in Relationship with Decrease in Fracture Risk of Women Exposed to Aromatase Inhibitors

Antonini, S., Pedersini, R., Birtolo, M.F., Baruch, N.L., Carrone, F., Jaafar, S., Ciafardini, A., Cosentini, D., Laganà, M., Torrisi, R., Farina, D., Leonardi, L., Balzarini, L., Vena, W., Bossi, A.C., Zambelli, A., Lania, A.G., Berruti, A. and Mazziotti, G.

EndocrinologyOncologySecondary Osteoporosis
See the science in practice

We help clinicians reveal more from routine imaging — every patient, every scan — for better care.

TBS Osteo™ is intended exclusively for healthcare professionals and is not available for purchase by the general public. TBS Osteo is a Class IIa medical device, CE marked under EU MDR 2017/745 (CE 2460). TBS Osteo is FDA 510(k) cleared (K243218) for use in the United States. TBS Osteo is included on the Australian Register of Therapeutic Goods (ARTG No. 528950) as "Inovanz Pty Ltd — X-ray system, diagnostic, general-purpose, application program software". Manufacturer: Medimaps Group SA, Chemin du Champ-des-Filles 36A, 1228 Plan-les-Ouates, Geneva, Switzerland. Always follow the instructions for use.

RBfracture™ is intended exclusively for healthcare professionals and is not available for purchase by the general public. RBfracture is a Class IIa medical device, CE marked under EU MDR 2017/745 (CE 0123). RBfracture is included on the Australian Register of Therapeutic Goods (ARTG No. 484605) as “Emergo Asia Pacific Pty Ltd T/a Emergo Australia - X-ray image interpretive software”. Manufacturer: Radiobotics ApS, Esplanaden 8C, 1tv, 1263, Copenhagen, Denmark. Always follow the instructions for use.

TBS Reveal™ is intended exclusively for healthcare professionals and is not available for purchase by the general public. TBS Reveal is a Class IIa medical device, CE marked under EU MDR 2017/745 (CE 2460). FDA clearance is pending; TBS Reveal is not available for clinical use in the United States. Manufacturer: Medimaps Group SA, Chemin du Champ-des-Filles 36A, 1228 Plan-les-Ouates, Geneva, Switzerland. Always follow the instructions for use.

TBS Ortho™ is currently under development and is not yet CE marked, FDA cleared, or otherwise registered for clinical use in any jurisdiction. It is not available for purchase or clinical use at this time.